We’re thrilled to announce that Apprentice has made the 2022 Inc. 5000 list, ranking #542 out of 5,000! We’re proud to be included among the most successful and fastest growing privately run companies in America.
We’d like to extend our heartfelt gratitude to our incredible team and our devoted clients who helped us reach this shared achievement. It truly takes a village, and we couldn’t have done it without you.
The Inc. 5000 list is the most prestigious ranking of the fastest-growing private companies in America. The list represents a unique look at the most successful companies within the economy’s most dynamic segment — its independent businesses.
“The accomplishment of building one of the fastest-growing companies in the U.S., in light of recent economic roadblocks, cannot be overstated. Inc. is thrilled to honor the companies that have established themselves through innovation, hard work, and rising to the challenges of today.”
— Scott Omelianuk, Inc. Editor in Chief
Starting in 1982, Inc. has cataloged America’s most successful privately held organizations in their annual Inc. 5000 list. To calculate their list, they rank companies by revenue growth of over a three-year period. Honorees include household staples such as Microsoft, Pandora, and Under Armour.
Our ranking in the top 10% on the 2022 Inc. 5000 list represents a 1,157% growth rate since 2021. The company also ranked 60th fastest in the software industry and 17th in its home state of New Jersey.
Apprentice’s award-winning Tempo Manufacturing Cloud platform is the first manufacturing platform that serves the entire drug production lifecycle.
Tempo helps operations scale up from preclinical experimentation to clinical trials to get to full production faster. Once in the commercial stage, production can then be scaled out across teams and sites to maximize output.
“We are honored to receive this recognition. Our phenomenal growth is a direct reflection of our mission to help pharma manufacturers get medicine to patients faster. It illustrates how the life sciences industry is increasingly turning to modern technology to bring revolutionary therapeutics to market.”
— Angelo Stracquatanio, Apprentice CEO & Co-Founder
Our Tempo platform provides the power and security you need to make high-quality, regulatory compliant therapeutics at scale. With shared capabilities, your teams can start operating without stopping for data, knowledge, or process transfer between siloed systems.
We couldn’t be prouder of our team’s hard work and the achievements we’ve reached so far this year! Read on for two more industry recognitions we’ve recently received.
2022’s been quite a year, but it’s only half over! We’ve got our sights set on continued growth as we keep discovering new and more efficient ways to bring our clients the utmost in pharmaceutical computing software.
With $140M in funding, a 12x growth rate, and 512% net customer retention, we’re a trusted partner to modernize your operations and change the way drugs are made in your facility.
Learn how leading companies like Catalent, Synthego, and Bristol Myers Squibb are using Tempo to scale from drug discovery to patient delivery faster.
Looking for an Inc. 5000 company to call your own? Look no further! Apprentice is a fantastic place to work, and we’re always on the hunt for passionate life science problem-solvers to join our growing team. Check out our open positions today.